Oncologic and functional outcome, in giant cell tumor around the knee presented by pathological fracture, treated by extended curettage and cement /
النتائج الوظيفية ونتائج الاورام:في ورم الخلايا العملاقة حول الركبة المقدمه بكسورمرضية: والمعالجة بكحت موسع واسمنت
Baher Atef Kaissar ; Supervised Ahmed Nabawy Morrah , Walid Atef Ebeid , Wessam Gamal Eldin Abosenna
- Cairo : Baher Atef Kaissar , 2017
- 124 P. : charts , facsimiles ; 25cm
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Orthopedic Surgery
According to a Mayo Clinic series, giant cell tumors represent 5% of bone neoplasm. They typically occur in patients 20 to 40 years old, and there is a slight female predominance. The most common location for this tumor is the distal femur, followed closely by the proximal tibia. Most patients with giant cell tumors have progressive pain that often is related to activity initially and only later becomes evident at rest. The pain is rarely severe, unless a pathological fracture has occurred. In 10% to 30% of patients, pathological fractures are evident at initial examination. Radiographic findings often are diagnostic. The lesions are eccentrically located in the epiphyses of long bones and usually abut the subchondral bone. The lesion frequently expands or breaks through the cortex (2). Approximately one in five patients with giant cell tumor of bone presents with a pathologic fracture. However, recurrence rates after resection or curettage differ substantially in the literature and it is unclear when
Functional Outcome In giant cell tumor around Treated by extended curettage and cement